MiVs, abundant in protein content from M1 macrophages, have demonstrated inherent tumor-targeting properties, partly due to C-C chemokine receptor type 2 (CCR2)-rich membranes, encouraging the homing of donor cells to tumor sites (80). Here, CCR2 is linked to neoplasm.